Dr. Randy Grellner explains how remdesivir contributed to his patient's catastrophic kidney failure after…
2026-10-08 ·
About this video
Dr. Randy Grellner explains how remdesivir contributed to his patient's catastrophic kidney failure after his kidney function deteriorated dramatically during CV-19 hospitalization.
During Senator Ron Johnson's September 28, 2026 roundtable, Dr. Randy Grellner, an Oklahoma state senator and family physician, described the final days of John, a Navy veteran who had been his patient and friend for 18 years.
According to Dr. Grellner, John's creatinine rose from 1.4 to 3.7 within 24 hours of receiving antiviral treatment, while his kidney filtration rate (GFR) dropped from 53 to 17. By the third day, his creatinine reached 6, his GFR fell to 10, and he required emergency dialysis.
John was intubated, placed on a ventilator, and never regained consciousness. Dr. Grellner also described pressure ulcers, blood clots, and derogatory comments in John's medical records concerning his unVX status and previous ivermectin use.
When Senator Johnson asked whether the decision to discontinue remdesivir suggested doctors recognized its potential kidney toxicity, Dr. Grellner responded:
"It looked to me like it was the toxic effects of a drug."
He acknowledged that ventilation-related complications could also contribute to kidney injury but questioned why John's liver function improved while his kidneys deteriorated.
John ultimately died.
"When did medicine decide that disagreement cancels dignity? When did our hospitals begin acting as though a patient who made a different choice deserved less respect?"
On September 28, 2026, U.S. Senator Ron Johnson led a roundtable discussion titled "COVID-19 Hospital Protocols: Real Stories from Real People," examining COVID-era hospital treatment practices and patient experiences.
#covidhospitalprotocolroundtable
Full event:
https://rumble.com/v7g3rtm-live-sen.-ron-johnson-roundtable-covid-hospital-protocols-under-the-microsc.html?e9s=src_v1_s%2Csrc_v1_s_o
This entry reproduces source material or commentary; its claims are not independently verified by this archive.
